FIELD: medicine; pharmacology; chemical-pharmaceutical industry.
SUBSTANCE: group of inventions is intended for treating functional diseases of gastrointestinal organs. Combination for treating functional gastrointestinal diseases contains effective amounts of trimebutine or a pharmaceutically acceptable salt thereof in combination with a substance selected from group comprising 4-oxo-4-(2,4,5-triethoxyphenyl)butyric acid, 4-(5-cyclohexyl-2,4-dimethoxyphenyl)-4-oxo-butyric acid, 4-methyl-7-sulphooxy-coumarin, 2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propionic acid and their pharmaceutically acceptable salts. Also provided is a drug for treating functional diseases of gastrointestinal organs in the form of tablets or capsules, placed in a pharmaceutically acceptable package, wherein the agent contains the above combination in a therapeutically effective amount.
EFFECT: group of inventions is a universal and effective agent for treating functional diseases of gastrointestinal organs.
36 cl, 21 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
BIPHENYLSULFONYLCYANAMIDES, METHOD FOR THEIR PREPARING AND THEIR APPLYING AS DRUGS | 1999 |
|
RU2247111C2 |
NEW COMPOSITIONS | 2021 |
|
RU2771565C1 |
NEW SALTS OF [2-(DIMETHYLAMINO)-2-PHENYLBUTYL]-3,4,5-TRIMETHOXYBENZOATE AND APPLICATION THEREOF | 2021 |
|
RU2777365C1 |
SUBSTITUTED 1-AMINOALKYL LACTAMS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR THEIR PREPARING | 2001 |
|
RU2243222C2 |
ORGANOSILICON COMPOUND AND THEIR USING | 2004 |
|
RU2303594C2 |
BENZIMIDAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | 2008 |
|
RU2451017C2 |
DERIVATIVES OF TETRALONE AS ANTITUMOR AGENTS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2288220C2 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONА DERIVATIVES AND USING THEM IN TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2570423C2 |
CRYSTALLINE FORMS OF 3-CARBOXYPROPYL-AMINOTETRALIN COMPOUND | 2009 |
|
RU2512390C2 |
TETRAHYDROISOQUINOLIN-1-ONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, USEFUL AS BB2 ANTAGONIST | 2008 |
|
RU2479578C2 |
Authors
Dates
2020-10-06—Published
2019-04-23—Filed